Lexicon Pharmaceuticals Inc LXRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
1.79quote price arrow down-0.10 (-5.29%)
Volume
2,042,048
52 week range
0.92 - 3.73
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.79
  • 52 Week High3.73
  • 52 Week High Date02/16/24
  • 52 Week Low0.92
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap440.764M
  • Shares Out246.24M
  • 10 Day Average Volume3.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change16.99

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.79
  • 52 Week High3.73
  • 52 Week High Date02/16/24
  • 52 Week Low0.92
  • 52 Week Low Date11/10/23
  • Market Cap440.764M
  • Shares Out246.24M
  • 10 Day Average Volume3.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change16.99

RATIOS/PROFITABILITY

  • EPS (TTM)-0.83
  • P/E (TTM)-2.16
  • Fwd P/E (NTM)-2.33
  • EBITDA (TTM)-185.355M
  • ROE (TTM)-102.73%
  • Revenue (TTM)2.311M
  • Gross Margin (TTM)94.98%
  • Net Margin (TTM)-8,376.55%
  • Debt To Equity (MRQ)34.57%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lexicon Pharmaceuticals Inc

 

Profile

MORE
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The Company pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other...
Raymond Debbane
Independent Chairman of the Board
Lonnel Coats
Chief Executive Officer, Director
Jeffrey Wade
President, Chief Financial Officer
Alan Main Ph.D.
Executive Vice President - Innovation and Chemical Sciences
Wendy Mcdermott
Vice President - Human Resources
Kristen Alexander
Vice President - Finance and Accounting
Address
8800 TECHNOLOGY FOREST PLACE
8800 TECHNOLOGY FOREST PLACE
The Woodlands, TX
77381
United States

Top Peers

SYMBOLLASTCHG%CHG
REPL
Replimune Group Inc
6.41-0.32-4.75%
SLRN
ACELYRIN Inc
4.68-0.20-4.10%
ITOS
Iteos Therapeutics Inc
17.44+5.25+43.07%
BMEA
Biomea Fusion Inc
10.65-0.79-6.91%
ANNX
Annexon Inc
4.75-0.35-6.86%